CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464348039
- Phone
- 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-30 | Jenkins John Kenneth Director | Grant or award | +2,783 | 2,816 | ||
| 2024-05-30 | CATLIN AVERY W Director | Grant or award | +2,783 | 4,350 | ||
| 2024-05-30 | Salzmann Peter Director | Grant or award | +2,783 | 2,783 | ||
| 2024-05-30 | Jacques Rachelle Suzanne Director | Grant or award | +2,783 | 2,783 | ||
| 2024-05-30 | Ben Yong Director | Grant or award | +2,783 | 2,783 | ||
| 2024-05-30 | HOLMER ALAN F Director | Grant or award | +2,783 | 4,162 | ||
| 2024-05-30 | Altmeyer Anne Director | Grant or award | +2,783 | 2,783 | ||
| 2024-05-16 | Salzmann Peter Director | Grant or award · Stock Option (right to buy) | +2,783 | 2,783 | ||
| 2024-05-16 | Jenkins John Kenneth Director | Grant or award · Stock Option (right to buy) | +2,783 | 2,783 | ||
| 2024-05-16 | Jacques Rachelle Suzanne Director | Grant or award · Stock Option (right to buy) | +2,783 | 2,783 | ||
| 2024-05-16 | HOLMER ALAN F Director | Grant or award · Stock Option (right to buy) | +2,783 | 2,783 | ||
| 2024-05-16 | CATLIN AVERY W Director | Grant or award · Stock Option (right to buy) | +2,783 | 2,783 | ||
| 2024-05-16 | Ben Yong Director | Grant or award · Stock Option (right to buy) | +2,783 | 2,783 | ||
| 2024-05-16 | Altmeyer Anne Director | Grant or award · Stock Option (right to buy) | +2,783 | 2,783 | ||
| 2024-04-10 | Moran Sean F. Chief Financial Officer | Option exercise | +1,787 | $30.00 | $54K | 48,605 |
| 2024-04-10 | Moran Sean F. Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −1,787 | 0 | ||
| 2024-03-08 | Cormorant Asset Management, LP 10% owner | Purchase | +29,342 | $41.23 | $1.2M | 1,754,342 |
| 2024-03-08 | Cormorant Asset Management, LP 10% owner | Purchase | +24,983 | $42.25 | $1.1M | 1,779,325 |
| 2024-03-08 | Cormorant Asset Management, LP 10% owner | Purchase | +18,548 | $43.26 | $802K | 1,797,873 |
| 2024-03-08 | Cormorant Asset Management, LP 10% owner | Purchase | +61,668 | $44.62 | $2.8M | 1,859,541 |
Page 7 of 10 · 200 trades